Anthem Biosciences (NSE:ANTHEM) EV-to-FCF: (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ANTHEM Anthem Biosciences Ltd NSE:ANTHEM
23 GF Score
Price ₹777.85
! 5 Warning Signs
View Full Analysis

What is Anthem Biosciences EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Anthem Biosciences's Enterprise Value is ₹428,083 Mil. Anthem Biosciences's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was ₹0 Mil. Therefore, Anthem Biosciences's EV-to-FCF for today is .

The historical rank and industry rank for Anthem Biosciences's EV-to-FCF or its related term are showing as below:

NSE:ANTHEM' s EV-to-FCF Range Over the Past 10 Years
Min: 0   Med: 0   Max: 67.69
Current: 67.69

During the past 5 years, the highest EV-to-FCF of Anthem Biosciences was 67.69. The lowest was 0.00. And the median was 0.00.

NSE:ANTHEM's EV-to-FCF is ranked worse than
83.43% of 338 companies
in the Biotechnology industry
Industry Median: 15.175 vs NSE:ANTHEM: 67.69

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-23), Anthem Biosciences's stock price is ₹777.85. Anthem Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 was ₹10.150. Therefore, Anthem Biosciences's PE Ratio (TTM) for today is 76.64.

Anthem Biosciences  (NSE:ANTHEM) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Anthem Biosciences's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=777.85/10.150
=76.64

Anthem Biosciences's share price for today is ₹777.85.
Anthem Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹10.150.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Anthem Biosciences EV-to-FCF Related Terms

Anthem Biosciences EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Anthem Biosciences's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anthem Biosciences EV-to-FCF Chart

Anthem Biosciences Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
0.00 0.00 0.00 0.00 56.81

Anthem Biosciences Quarterly Data
Mar22 Mar23 Mar24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 56.81 0.00

NSE:ANTHEM vs VRTX, REGN, ALNY: EV-to-FCF Comparison

For the Biotechnology subindustry, Anthem Biosciences's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anthem Biosciences EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anthem Biosciences's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Anthem Biosciences's EV-to-FCF falls into.


NSE:ANTHEM
23GF Score
Anthem Biosciences Ltd NSE:ANTHEM
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anthem Biosciences EV-to-FCF Calculation

Anthem Biosciences's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=428083.389/0
=

Anthem Biosciences's current Enterprise Value is ₹428,083 Mil.
Anthem Biosciences's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anthem Biosciences Business Description

Other Exchanges 544449:India
Address No. 49, F1 & F2, Canara Bank Road, Bommasandra Industrial Area, Phase 1, Bommasandra, Bangalore, KA, IND, 560 099
Anthem Biosciences Ltd is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. It is one of the few companies in India with integrated New Chemical Entity (NCE) and New Biological Entity (NBE) capabilities across drug discovery, development, and commercial manufacturing. As a one-stop service provider, It serves a range of customers, encompassing innovator-focused emerging biotech and large pharmaceutical companies globally.
23GF Score

Get the complete analysis for NSE:ANTHEM

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹777.85
Price